PLAQUENIL (Plaquenil sulfate 200 mg)
Pill imprint PLAQUENIL has been identified as Plaquenil sulfate 200 mg.
Hydroxychloroquine is used in the treatment of systemic lupus erythematosus; rheumatoid arthritis; undifferentiated connective tissue disease; sjogren's syndrome; lyme disease, arthritis (and more), and belongs to the drug classes antimalarial quinolines, antirheumatics. FDA has not classified the drug for risk during pregnancy. Hydroxychloroquine 200 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Imprint:
- PLAQUENIL
- Strength:
- 200 mg
- Color:
- White
- Size:
- 12.00 mm
- Shape:
- Figure eight-shape
- Availability:
- Prescription only
- Drug Class:
- Antimalarial quinolines
Antirheumatics - Pregnancy Category:
- N - Not classified
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Sanofi-Aventis
- National Drug Code (NDC):
- 00024-1562
- Inactive Ingredients:
- calcium phosphate dibasic anhydrous
hypromelloses
magnesium stearate
polyethylene glycol 400
polysorbate 80
corn starch
titanium dioxide
| NDC Code | Manufacturer / Repackager |
|---|---|
| 66993-0057 | Prasco Laboratories |
| 42291-0335 | AvKare, Inc. |
Note: Inactive ingredients may vary.
More about hydroxychloroquine
Consumer resources
- Other brands: Plaquenil
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
